FibroGen Profit Margin

The latest profit margin for FGEN is 3968.63% as of June 2026. That compares with 2.83% in the prior-year period — up 140048.8% year over year. That is above the Healthcare sector average of 21.34%. Investors often review this figure alongside FibroGen's historical trend and sector peers before judging valuation or financial health.

Over the past year, FGEN's profit margin moved from 2.83% to 3968.63% — a 140048.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in FibroGen's valuation or profitability profile.

Against Healthcare companies, FGEN currently prints 3968.63% for profit margin, while the sector average sits near 21.34%. That is roughly 18501.3% above the sector mean. Large gaps often invite a closer look at FibroGen's growth, margins, and balance sheet.

Profit Margin shows how effectively FibroGen converts resources into returns. At 3968.63%, FGEN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 2.83% in the prior-year period — up 140048.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting FGEN's profit margin (3968.63%), review year-over-year change from 2.83%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.